We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RYZ
2801
Ryerson Holding Corp
RYZ
$1.4B
| $290K | ﹤0.01% |
19,884
-6,570
| -25% | -$104K |
|
2802
eGain
EGAN
$202M
| $289K | ﹤0.01% |
25,191
-3,936
| -14% | -$40.2K |
|
2803
GT Biopharma
GTBP
$10.9M
| $289K | ﹤0.01% |
+621
| New | +$258K |
|
|
LITS
2804
Lite Strategy Inc
LITS
$31.6M
| $288K | ﹤0.01% |
5,058
-752
| -13% | -$48.3K |
|
|
CURO
2805
DELISTED
CURO Group Holdings Corp.
CURO
| $288K | ﹤0.01% |
16,940
-964
| -5% | -$15K |
|
|
CSLT
2806
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $288K | ﹤0.01% |
+109,453
| New | +$204K |
|
|
AXDX
2807
DELISTED
Accelerate Diagnostics
AXDX
| $286K | ﹤0.01% |
3,549
-171
| -5% | -$13.6K |
|
|
PVBC
2808
DELISTED
Provident Bancorp
PVBC
| $286K | ﹤0.01% |
17,521
-1,273
| -7% | -$20.5K |
|
2809
Village Super Market
VLGEA
$640M
| $286K | ﹤0.01% |
12,167
-1,342
| -10% | -$32.7K |
|
|
DSKE
2810
DELISTED
Daseke, Inc. Common Stock
DSKE
| $286K | ﹤0.01% |
44,115
-7,574
| -15% | -$55K |
|
|
LBC
2811
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $286K | ﹤0.01% |
24,123
-5,980
| -20% | -$70.5K |
|
2812
Neuronetics
STIM
$157M
| $285K | ﹤0.01% |
+17,803
| New | +$246K |
|
|
GPX
2813
DELISTED
GP Strategies Corp.
GPX
| $285K | ﹤0.01% |
18,128
-2,361
| -12% | -$38.3K |
|
2814
Pure Cycle
PCYO
$257M
| $284K | ﹤0.01% |
20,521
-1,337
| -6% | -$19.1K |
|
2815
KVH Industries
KVHI
$162M
| $283K | ﹤0.01% |
23,031
-3,943
| -15% | -$53.3K |
|
2816
Mid Penn Bancorp
MPB
$957M
| $283K | ﹤0.01% |
10,327
+70
| +0.7% | +$1.91K |
|
|
ONTF
2817
DELISTED
ON24
ONTF
| $283K | ﹤0.01% |
7,978
+515
| +7% | +$20.1K |
|
|
JNCE
2818
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $282K | ﹤0.01% |
41,406
+13,559
| +49% | +$113K |
|
|
MRLN
2819
DELISTED
Marlin Business Services Corp
MRLN
| $282K | ﹤0.01% |
12,384
-2,063
| -14% | -$43.2K |
|
2820
Ouster
OUST
$3.07B
| $278K | ﹤0.01% |
+2,224
| New | +$237K |
|
2821
Blue Ridge Bankshares
BRBS
$331M
| $277K | ﹤0.01% |
+15,792
| New | +$259K |
|
2822
InnovAge Holding
INNV
$1.49B
| $274K | ﹤0.01% |
+12,842
| New | +$294K |
|
|
CASA
2823
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $274K | ﹤0.01% |
30,884
-3,352
| -10% | -$29.7K |
|
2824
Porch Group
PRCH
$1.75B
| $273K | ﹤0.01% |
+14,098
| New | +$232K |
|
2825
Mistras Group
MG
$498M
| $271K | ﹤0.01% |
27,542
-1,924
| -7% | -$20.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.